Chlordiazepoxide Hydrochloride And Clidinium Bromide Capsule
Product Images NDC 59651-524

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Chlordiazepoxide Hydrochloride And Clidinium Bromide (NDC 59651-524). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (5 mg/2.5 mg (100 Capsules Bottle))

This is a description for a medication called Chlordiazepoxide Hydrochloride and Clidinium Bromide Capsules, USP. Each capsule contains 5 mg of Chlordiazepoxide hydrochloride USP and 2.5 mg of clinidium bromide USP. The usual adult dosage is one or two capsules taken 3 or 4 times a day, before meals and at bedtime. It is important to read the enclosed package insert for additional dosage recommendations and other prescribing information. The medication should be stored at 20° to 25°C (68° to 77°F), with excursions permitted to 15° to 30°C (59° to 86°F), and kept out of reach of children. It is distributed by Aurobindo Pharma USA, Inc. and made in India.*

FDA Label Image

Chemical Structure1 (Chlorclid Str1)

FDA Label Image

Chemical Structure2 (Chlorclid Str2)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.